Stockreport

Sesen Bio to Present at the Canaccord Genuity 39th Annual Growth Conference

Sesen Bio, Inc.  (SESN) 
Last sesen bio, inc. earnings: 11/12 07:00 am Check Earnings Report
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patie [Read more]